标题
RANKL Inhibitors Induce Osteonecrosis of the Jaw in Mice With Periapical Disease
作者
关键词
-
出版物
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 29, Issue 4, Pages 843-854
出版商
Wiley
发表日期
2013-10-12
DOI
10.1002/jbmr.2097
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Systemic RANK-Fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts
- (2015) Toru Akiyama et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Porphyromonas gingivalis Infection-Associated Periodontal Bone Resorption Is Dependent on Receptor Activator of NF-κB Ligand
- (2013) Xiaozhe Han et al. INFECTION AND IMMUNITY
- Periapical Disease and Bisphosphonates Induce Osteonecrosis of the Jaws in Mice
- (2013) Ben Kang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Absence of Exposed Bone Following Dental Extraction in Beagle Dogs Treated With 9 Months of High-Dose Zoledronic Acid Combined With Dexamethasone
- (2013) Matthew R. Allen et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Bisphosphonate Therapy and Atypical Fractures
- (2013) Anas Saleh et al. ORTHOPEDIC CLINICS OF NORTH AMERICA
- Bisphosphonate related osteonecrosis of the jaw: A minipig large animal model
- (2012) Christoph Pautke et al. BONE
- The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease
- (2012) G. N. Belibasakis et al. INTERNATIONAL ENDODONTIC JOURNAL
- Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis
- (2012) J Ignacio Aguirre et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone
- (2012) Jahan Abtahi et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
- (2012) David L. Lacey et al. NATURE REVIEWS DRUG DISCOVERY
- High- and low-dose OPG–Fc cause osteopetrosis-like changes in infant mice
- (2012) Renee Bargman et al. PEDIATRIC RESEARCH
- Safety of Bisphosphonates
- (2012) Catalina Orozco et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients
- (2012) George Dranitsaris et al. SUPPORTIVE CARE IN CANCER
- New insights into osteoclastogenic signaling mechanisms
- (2012) Tomoki Nakashima et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Antiresorptives and Osteonecrosis of the Jaw
- (2012) Junro Yamashita et al. Journal of Evidence-Based Dental Practice
- Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
- (2011) F. Saad et al. ANNALS OF ONCOLOGY
- Potential pathophysiological mechanisms in osteonecrosis of the jaw
- (2011) Regina Landesberg et al. Annals of the New York Academy of Sciences
- Modulation of TNFSF expression in lymphoid tissue inducer cells by dendritic cells activated with Toll-like receptor ligands
- (2011) Sin-Suk Han et al. BMB Reports
- Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody
- (2011) Paul J. Kostenuik et al. BONE
- Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
- (2011) Michael S. Ominsky et al. BONE
- Safety of Long-Term Bisphosphonate Therapy for the Management of Osteoporosis
- (2011) E. Michael Lewiecki DRUGS
- Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat
- (2011) Tara L Aghaloo et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis
- (2011) Huaiping Yuan et al. JOURNAL OF CLINICAL PERIODONTOLOGY
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Advances in osteoclast biology: old findings and new insights from mouse models
- (2011) James R. Edwards et al. Nature Reviews Rheumatology
- Extraction socket healing in rats treated with bisphosphonate: Animal model for bisphosphonate related osteonecrosis of jaws in multiple myeloma patients
- (2011) M. Ali-Erdem et al. Medicina Oral Patologia Oral y Cirugia Bucal
- Bisphosphonates Cause Osteonecrosis of the Jaw-Like Disease in Mice
- (2010) Yanming Bi et al. AMERICAN JOURNAL OF PATHOLOGY
- Denosumab and bisphosphonates: Different mechanisms of action and effects
- (2010) Roland Baron et al. BONE
- Effect of alendronate on alveolar bone resorption and angiogenesis in rats with experimental periapical lesions
- (2010) H. Xiong et al. INTERNATIONAL ENDODONTIC JOURNAL
- Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice
- (2010) Takashi Kikuiri et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Long-Term Use of Bisphosphonates in Osteoporosis
- (2010) Nelson B. Watts et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats
- (2010) Pía López-Jornet et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
- (2010) David Thomas et al. LANCET ONCOLOGY
- Osteoclasts and odontoclasts: signaling pathways to development and disease
- (2010) Z Wang et al. ORAL DISEASES
- Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin
- (2009) Xiaodong Li et al. BONE
- RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis
- (2009) Margareta Verdrengh et al. BONE
- One Year of Transgenic Overexpression of Osteoprotegerin in Rats Suppressed Bone Resorption and Increased Vertebral Bone Volume, Density, and Strength*
- (2009) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data
- (2009) Matthew R. Allen et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Transplantation of Mesenchymal Stem Cells Overexpressing RANK-Fc or CXCR4 Prevents Bone Loss in Ovariectomized Mice
- (2009) Sun Wook Cho et al. MOLECULAR THERAPY
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mandibular necrosis in beagle dogs treated with bisphosphonates
- (2009) DB Burr et al. Orthodontics & Craniofacial Research
- Functions of RANKL/RANK/OPG in bone modeling and remodeling
- (2008) Brendan F. Boyce et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Bisphosphonates and Osteonecrosis of the Jaw: Moving from the Bedside to the Bench
- (2008) Matthew R. Allen CELLS TISSUES ORGANS
- Role of full-length osteoprotegerin in tumor cell biology
- (2008) G. Zauli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Pathophysiological roles of osteoprotegerin (OPG)
- (2008) Penny Reid et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- RANKL Inhibition with Osteoprotegerin Increases Bone Strength by Improving Cortical and Trabecular bone Architecture in Ovariectomized Rats
- (2008) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL*
- (2008) Paul J Kostenuik et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway
- (2008) Estelle Chamoux et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients
- (2008) Stephen T. Sonis et al. ORAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started